BioCardia
San Carlos
About BioCardia
BioCardia is a clinical-stage regenerative medicine company. We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMP™ and CardiALLO™ therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $54.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:BCDA
- Website: biocardia.com
- Phone: +1 6506313731
Industries & Categories
Alternative Medicine, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biocardia-166479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.